Latest stories on KYNB
Kyntra Bio initiated with a Buy at Maxim on mCRPC potential
The Fly64 · neutralanalyst
Kyntra Bio initiated with a Buy at Maxim
The Fly63 · neutralanalyst
KYNTRA BIO, INC. (KYNB) files 8-K
SEC 8-K28 · bearishgeneral
KYNTRA BIO, INC. (KYNB) files 8-K
SEC 8-K50 · neutralgeneral
Kyntra Bio appoints Singer to its board of directors
The Fly55 · neutralgeneral
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
Business Insider50 · neutralgeneral
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
GlobeNewswire50 · neutralgeneral
Kyntra Bio initiated with a Buy at Lake Street
The Fly61 · neutralanalyst
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
Oppenheimer reiterates Kyntra Bio stock rating on debt reduction
Investing.com Analyst Ratings56 · neutralanalyst
KYNTRA BIO, INC. (KYNB) files 8-K
SEC 8-K50 · neutralgeneral
Kyntra Bio cuts max royalty cap to $65M from $125M, pays $42.6M upfront
The Fly63 · neutralgeneral
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Business Insider67 · bullishgeneral
Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Kyntra Bio, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Kyntra Bio reports Q2 EPS $2.96, consensus ($3.18)
The Fly38 · neutralearnings
Kyntra Bio targets FG-3246 median rPFS of 10 months or greater as it plans roxadustat Phase III start in Q4 2026
Seeking Alpha63 · neutralproduct/pr
Kyntra Bio, Inc. (KYNB) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
KYNTRA BIO, INC. (KYNB) files 8-K
SEC 8-K50 · neutralgeneral
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan59 · neutralearnings
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire59 · neutralearnings
FibroGen Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Kyntra Bio to Report Second Quarter 2026 Financial Results
StockTitan50 · neutralgeneral
KYNTRA BIO, INC. (KYNB) files 8-K
SEC 8-K50 · neutralgeneral